Hormonal treatment of pancreatic carcinoma: a phase II study of LHRH agonist goserelin plus hydrocortisone

Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route.

Mitch Dowsett, Paul E. Goss, TJ Powles et al. · PubMed · 1987 · 240 citations

Breast Oncology, Gynecology, Pharmacotherapy +18

Initial clinical evaluation of an immunoradiometric assay for CA 19‐9 using the nci serum bank

Roy E. Ritts, Bert C. Del Villano, V. L. W. Go et al. · International Journal of Cancer · 1984 · 212 citations

Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones.

Tommie W. Redding, Andrew V. Schally · Proceedings of the National Academy of Sciences · 1984 · 159 citations · Full text

Oncology, Pancreatic Cancer, Hypothalamic Hormones +15

Oestrogen receptor proteins in malignant and fetal pancreas.

B Greenway, M. J. Iqbal, P J Johnson et al. · BMJ · 1981 · 145 citations · Full text

Developmental Biology, Pancreatic Cancer, Medicine +14

Endocrine and Therapeutic Effects of Aminoglutethimide in Premenopausal Patients with Breast Cancer

Adrian L. Harris, Mitch Dowsett, S.L. Jeffcoate et al. · The Journal of Clinical Endocrinology & Metabolism · 1982 · 99 citations

Breast Oncology, Premenopausal Patients, Gynecology +16